中文名称: | (2S,2'S)-[[(2R, 5R)-1-[3,5-二氟-4-(4-(4-氟苯基)哌啶-1-基)苯胺]-2,5-双四氢吡咯基]双[6-氟-2-(2S)-2-四氢吡咯-1H-苯并咪唑-2,5-二基)]双(1-四氢吡咯甲酸叔丁酯) |
中文同义词: | (2S,2'S)-[[(2R, 5R)-1-[3,5-二氟-4-(4-(4-氟苯基)哌啶-1-基)苯胺]-2,5-双四氢吡咯基]双[6-氟-2-(2S)-2-四氢吡咯-1H-苯并咪唑-2,5-二基)]双(1-四氢吡咯甲酸叔丁酯);2S,2'S)-[[(2R,5R)-1-[3,5-二氟-4-(4-(4-氟苯基)哌啶-1-基)苯胺]-2;ABT-530/P N-1步中间体;P-N-2;(2S,2'S)-2,2'-[[(2R,5R)-1-[3,5-二氟-4-[4-(4-氟苯基)-1-哌啶基]苯基]-2,5-吡咯烷二基]二(6-氟-1H-苯并咪唑-5,2-二基)]二-1-吡咯烷羧酸二叔;(2S,2'S)-2,2'-[[(2R,5R)-1-[3,5-二氟-4-[4-(4-氟苯基)-1-哌啶基]苯基]-2,5-吡咯烷二基]二(6-氟-1H-苯并咪唑-5,2-二基)]二-1-吡咯烷羧酸二叔丁酯;PIBRENTASVIR中间体1;(2S,2'S)-[[(2R, 5R)-1-[3,5-二氟-4-(4-(4-氟苯基)哌啶-1-基)苯胺]-2,5-双四氢吡咯基]双[6-氟-2-(2S)-2-四氢吡咯-1H-苯并咪唑-2,5-二基)] |
英文名称: | (2S,2'S)-[[(2R, 5R)-1-[3,5-difluoro-4-(4-(4- fluorophenyl)-1-piperidinyl)phenyl]-2,5-pyrrolidinediyl]bis[6-fluoro-2-(2S)-2-pyrrolidinyl 1H-benzimidzol e-2,5-diyl)]bis(1-pyrrolidinecarboxylic acid, 1,1'-bis(1,1'-dimethylethyl)ester |
英文同义词: | (2S,2'S)-[[(2R, 5R)-1-[3,5-difluoro-4-(4-(4- fluorophenyl)-1-piperidinyl)phenyl]-2,5-pyrrolidinediyl]bis[6-fluoro-2-(2S)-2-pyrrolidinyl 1H-benzimidzol e-2,5-diyl)]bis(1-pyrrolidinecarboxylic acid, 1,1'-bis(1,1'-dimethylethyl)ester;(2S,2'S)-[[(2R,5R)-1-[3,5-difluoro-4-(4-(4-fluorophenyl)-1-piperidinyl)phenyl]-2;(2S,2'S)-[[(2R,5R)-1-[3,5-Difluoro-4-[4-(4-fluorophenyl)-1-piperidinyl]phenyl]-2,5-pyrrolidinediyl]bis(6-fluoro-1H-benzimidazole-5,2-diyl)]bis-1-pyrrolidinecarboxylic Acid 1,1'-Bis(1,1-dimethylethyl) Ester;Pibrentasvir intermediate 1;(2S,2'S)-[[(2R,5R)-1-[3,5-difluoro-4-(4-(4-fluorophenyl)-1-p...;Pibrentasvir intermediate;ABT-530/P intermediate;Pibrentasvir Impurity 2 |
CAS号: | 1890114-11-0 |
分子式: | C53H59F5N8O4 |
分子量: | 967.1 |
EINECS号: | 824-169-2 |
Mol文件: | 1890114-11-0.mol |